TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36017021

Group type: EXPERIMENTAL
Intervention: CT-guided laparoscopic radical gastrectomy with the FBP reconstruction algorithm
Number of subjects: 56

Group type: COMPARATOR
Intervention: CT-guided laparoscopic radical gastrectomy (control group)
Number of subjects: 56
Study: 34871488

Group type: EXPERIMENTAL
Intervention: Monthly combined injectable contraceptives (CIC)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive pills (COC)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Copper intrauterine device (IUD)
Number of subjects: 124
Study: 33988887

Group type: EXPERIMENTAL
Intervention: 0.2% Thiamidol applied twice a day for 90 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: 4% hydroquinone cream applied at bedtime for 90 days
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 0.2% Thiamidol
Number of subjects: 50

Group type: COMPARATOR
Intervention: 4% hydroquinone cream
Number of subjects: 50
Study: 32191598

Group type: EXPERIMENTAL
Intervention: Testosterone administration (10 mg daily for 10 weeks)
Number of subjects: 35
Study: 33075840

Group type: EXPERIMENTAL
Intervention: Nasal high-frequency oscillatory ventilation (NHFOV)
Number of subjects: 27
Study: 32057739

Group type: EXPERIMENTAL
Intervention: Silodosin 8mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32755441

Group type: EXPERIMENTAL
Intervention: Problem-solving, Story-bridge mental health literacy programme (3-hour duration)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Plain language basic brochure about mental health issues
Number of subjects: 140
Study: 35606235

Group type: EXPERIMENTAL
Intervention: S‐268019‐b recombinant protein vaccine (5 μg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: S‐268019‐b recombinant protein vaccine (10 μg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33394391

Group type: EXPERIMENTAL
Intervention: 10-30% fly ash amended soil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40-50% fly ash amended soil
Number of subjects: 0
Study: 34999764

Group type: EXPERIMENTAL
Intervention: Baduanjin combined with elastic band exercise
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group (CHF community care)
Number of subjects: 136
Study: 34912887

Group type: EXPERIMENTAL
Intervention: High-quality nursing mode
Number of subjects: 72

Group type: COMPARATOR
Intervention: Routine nursing mode (Control)
Number of subjects: 72
Study: 32057612

Group type: EXPERIMENTAL
Intervention: Simple Head Extension (SHE)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Flexion Position (FP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison of SHE and FP
Number of subjects: 100
Study: 32016310

Group type: EXPERIMENTAL
Intervention: Iron isomaltoside, 1000 mg on day 0
Number of subjects: 245

Group type: COMPARATOR
Intervention: Ferric carboxymaltose, 750 mg infused on days 0 and 7
Number of subjects: 245
Study: 34428717

Group type: EXPERIMENTAL
Intervention: ADD group (n = 15) consuming pecans as part of a free-living diet
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: SUB group (n = 16) substituting pecans for isocaloric foods from their habitual diet
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (n = 16)
Number of subjects: 47
Study: 33031156

Group type: EXPERIMENTAL
Intervention: Facility-based screening and contact investigation of newly identified TB cases
Number of subjects: 2179
Study: 36058174

Group type: EXPERIMENTAL
Intervention: Lobectomy
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Segmentectomy
Number of subjects: 108
Study: 34422243

Group type: EXPERIMENTAL
Intervention: Echocardiography based on deep learning algorithm (observation group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine echocardiography (control group)
Number of subjects: 80
Study: 33308929

Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Mental Practice (MP)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (relaxation intervention)
Number of subjects: 31
Study: 32281738

Group type: EXPERIMENTAL
Intervention: Cranberry juice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo juice
Number of subjects: 0
Study: 35897147

Group type: EXPERIMENTAL
Intervention: Anti-aging daily serum (AADS) containing sunflower sprout extract (SSE), used twice daily for 7 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Anti-aging daily serum (AADS) in combination with anti-aging facial moisturizer (AAFM), used twice daily for 7 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study: 34326043

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole 18 mg/kg two times per day (36 mg/kg/day) for 3 months
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo two times per day for 3 months
Number of subjects: 158
Study: 32616067

Group type: EXPERIMENTAL
Intervention: Daily hydroxychloroquine
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Weekly hydroxychloroquine
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study: 35287641

Group type: EXPERIMENTAL
Intervention: SRP + minocycline hydrochloride (Exp 1)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: SRP + 809 nm diode laser + minocycline hydrochloride (Exp 2)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Scaling and root planning (SRP) (Control group)
Number of subjects: 92
Study: 32425361

Group type: EXPERIMENTAL
Intervention: Lianhuaqingwen capsules (4 capsules, thrice daily for 14 days)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Usual treatment alone
Number of subjects: 284
Study: 33084049

Group type: EXPERIMENTAL
Intervention: Rectus femoris transfer (RFT) as part of single-event multilevel surgery (SEMLS)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (no RFT)
Number of subjects: 129
Study: 35397305

Group type: EXPERIMENTAL
Intervention: Fascial release technique in addition to conventional physiotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional physiotherapy (hot pack, interferential current, exercise program)
Number of subjects: 30
Study: 34325942

Group type: EXPERIMENTAL
Intervention: Dorsal fiber-splitting capsulotomy approach (FSC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Closure with suture anchors in the FSC group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Closure with standard running suture in the FSC group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dorsal window approach
Number of subjects: 24
Study: 32336645

Group type: EXPERIMENTAL
Intervention: Enzalutamide plus ADT
Number of subjects: 1150

Group type: COMPARATOR
Intervention: Placebo plus ADT
Number of subjects: 1150
Study: 35708181

Group type: EXPERIMENTAL
Intervention: LYR‐210 (7500 µg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LYR‐210 (2500 µg)
Number of subjects: 24
Study: 34114120

Group type: EXPERIMENTAL
Intervention: Thallium (Tl)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Arsenic (As)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cadmium (Cd)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lead (Pb)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mercury (Hg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Beryllium (Be)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nickel (Ni)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Selenium (Se)
Number of subjects: 100
Study: 35511431

Group type: EXPERIMENTAL
Intervention: Trivalent admixture vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetravalent dengue vaccine (TV005)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-challenge response
Number of subjects: 0
Study: 32781898

Group type: EXPERIMENTAL
Intervention: Bystander Intervention Model (BIM) informed factsheet
Number of subjects: 281

Group type: COMPARATOR
Intervention: Standard factsheet about suicide and mental health
Number of subjects: 281
Study: 34709008

Group type: EXPERIMENTAL
Intervention: Electronic learning curriculum (ELC) with spectrogram monitors
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (standard residency curriculum without monitors)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Electronic learning curriculum (ELC)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (standard residency curriculum)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Patients cared for by ELC group
Number of subjects: 39

Group type: COMPARATOR
Intervention: Patients cared for by control group
Number of subjects: 39
Study: 32015556

Group type: EXPERIMENTAL
Intervention: bNAb therapy during ART interruption
Number of subjects: 9
Study: 35005990

Group type: EXPERIMENTAL
Intervention: Saline-based placebo (PBO; 99.45% PBS)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Sham (dry needle)
Number of subjects: 233
Study: 33812991

Group type: EXPERIMENTAL
Intervention: Mobile health support for diabetes self-care for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mobile health support for diabetes self-care
Number of subjects: 0
Study: 36206092

Group type: COMPARATOR
Intervention: G3 culture medium
Number of subjects: 120

Group type: COMPARATOR
Intervention: K-SICM culture medium
Number of subjects: 120
Study: 33657181

Group type: EXPERIMENTAL
Intervention: Rotating antibiotic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Presence of bacteriuria
Number of subjects: 0
Study: 35477817

Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond (CU)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: iBOND Universal (IU)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: G-Premio Bond (GP)
Number of subjects: 18
Study: 33221262

Group type: EXPERIMENTAL
Intervention: Simvastatin/Ezetimibe combination
Number of subjects: 1873

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1873

Group type: EXPERIMENTAL
Intervention: Baseline hyponatremia
Number of subjects: 1873

Group type: EXPERIMENTAL
Intervention: Incident hyponatremia
Number of subjects: 1873

Group type: COMPARATOR
Intervention: Normonatremia
Number of subjects: 1873
Study: 32421288

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 34
Study: 33831316

Group type: EXPERIMENTAL
Intervention: HCV treatment prescribed
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: HCV treatment initiated
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Posttreatment undetected HCV viral load
Number of subjects: 177
Study: 33046009

Group type: EXPERIMENTAL
Intervention: Flow-restorative yoga intervention (twice weekly for 1 hour for 12 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (maintaining normal daily routine)
Number of subjects: 38
Study: 35421008

Group type: EXPERIMENTAL
Intervention: HBOC‐201 infusion (up to 10 bags, equivalent to 3 units erythrocytes)
Number of subjects: 688

Group type: COMPARATOR
Intervention: Erythrocyte transfusion (up to 3 units)
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: HBOC‐201 infusion
Number of subjects: 688

Group type: COMPARATOR
Intervention: Erythrocyte transfusion
Number of subjects: 688
Study: 34800417

Group type: EXPERIMENTAL
Intervention: Erythropoietin (33,000 IU intravenously for 3 days)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo (intravenously for 3 days)
Number of subjects: 108
Study: 33308110

Group type: EXPERIMENTAL
Intervention: Integrative mind-body-medicine group program
Number of subjects: 57
Study: 36469000

Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617 plus best standard of care (BSoC)
Number of subjects: 831

Group type: COMPARATOR
Intervention: BSoC alone
Number of subjects: 831
Study: 33893449

Group type: EXPERIMENTAL
Intervention: Dietary changes in IMIDs
Number of subjects: 11230

Group type: COMPARATOR
Intervention: Dietary changes in Inflammatory bowel diseases
Number of subjects: 11230

Group type: EXPERIMENTAL
Intervention: Vegetable reduction in Crohn’s Disease
Number of subjects: 11230

Group type: EXPERIMENTAL
Intervention: Food groups associated with disease severity in IMIDs
Number of subjects: 11230
Study: 34058654

Group type: EXPERIMENTAL
Intervention: Early onset (EO) patients with early non-improvement after 2 weeks of therapy (<20% improvement)
Number of subjects: 889

Group type: COMPARATOR
Intervention: Late onset (LO) patients
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Early onset (EO) patients
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Electrolytes in early onset (EO) patients
Number of subjects: 889
Study: 32801202

Group type: EXPERIMENTAL
Intervention: 60 mg elemental iron as ferrous sulfate
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: 18 mg ferrous bisglycinate
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study: 34221273

Group type: EXPERIMENTAL
Intervention: Semi-surgical percutaneous dilatational tracheostomy (SSPDT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional percutaneous dilatational tracheostomy (CPDT)
Number of subjects: 160
Study: 33890342

Group type: EXPERIMENTAL
Intervention: Heat‐killed Gordonia bronchialis (GB)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Heat‐killed Rhodococcus coprophilus (RC)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: GB/RC combination
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 32586741

Group type: COMPARATOR
Intervention: Gelfoam
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Biodegradable Synthetic Polyurethane Foam (BSPF)
Number of subjects: 82
Study: 32207836

Group type: EXPERIMENTAL
Intervention: Oral naloxone coadministration with ticagrelor and morphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ticagrelor and morphine without naloxone
Number of subjects: 0
Study: 33990490

Group type: EXPERIMENTAL
Intervention: Adherence Clubs (ACs)
Number of subjects: 569

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 569
Study: 35961757

Group type: EXPERIMENTAL
Intervention: Nordic walking (NW)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous intensity continuous training (MICT)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: All interventions (HIIT, MICT, NW)
Number of subjects: 130
Study: 33189483

Group type: EXPERIMENTAL
Intervention: 2-week nutritional prehabilitation program
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1-week nutritional prehabilitation program
Number of subjects: 40
Study: 33051342

Group type: EXPERIMENTAL
Intervention: PD-1/PD-L1 inhibitors (monotherapy)
Number of subjects: 109
Study: 34854214

Group type: EXPERIMENTAL
Intervention: Acupressure at Neiguan (PC6) and Shenmen (HT7) acupoints thrice a day for 2 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 100
Study: 32853647

Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 32493473

Group type: EXPERIMENTAL
Intervention: Allogeneic donor CD362 enriched human umbilical cord derived mesenchymal stromal cells (REALIST ORBCEL‐C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Plasma‐Lyte 148 Solution for Infusion (200mls)
Number of subjects: 60
Study: 35618613

Group type: EXPERIMENTAL
Intervention: I Pass the Baton (IPB) methodology; face-to-face training session, training on how to use the IPB, inserting the IPB chart into the patient file, training leaflet, and installing a poster in the ward.
Number of subjects: 65

Group type: COMPARATOR
Intervention: SBAR (Situation, Background, Assessment, Recommendation) used as routine practice in the control group.
Number of subjects: 65
Study: 32979134

Group type: EXPERIMENTAL
Intervention: Supervised physical activity plus motivationally-enhanced behavioral counseling (PA + BC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Supervised physical activity plus standard exercise counseling (PA + EC)
Number of subjects: 26
Study: 32816313

Group type: EXPERIMENTAL
Intervention: Newborn Behavioral Observations (NBO)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 38
Study: 34489159

Group type: EXPERIMENTAL
Intervention: Hearing aids (100% gain targets)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham hearing aids (flat 30 dB HL)
Number of subjects: 25
Study: 32141277

Group type: EXPERIMENTAL
Intervention: Whey Protein Isolate (WPI)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Whey Protein Concentrate (WPC)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 31
Study: 35262624

Group type: EXPERIMENTAL
Intervention: HIPEC (41.5 °C, 75 mg/m2 of cisplatin, 90 minutes)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: HIPEC (Interval cytoreductive surgery after neoadjuvant chemotherapy)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control (Interval cytoreductive surgery after neoadjuvant chemotherapy)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: HIPEC (Primary cytoreductive surgery)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control (Primary cytoreductive surgery)
Number of subjects: 184
Study: 32529637

Group type: EXPERIMENTAL
Intervention: LNG‐IUS
Number of subjects: 2511

Group type: COMPARATOR
Intervention: Other medical therapy
Number of subjects: 2511
Study: 36001055

Group type: EXPERIMENTAL
Intervention: PEG‐rhG‐CSF
Number of subjects: 100

Group type: COMPARATOR
Intervention: rhG‐CSF
Number of subjects: 100
Study: 33589554

Group type: EXPERIMENTAL
Intervention: apremilast 20 mg twice daily
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: apremilast 30 mg twice daily
Number of subjects: 490

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 490
Study: 2010180594

Group type: EXPERIMENTAL
Intervention: Methylphenidate (15 mg, twice a day for one month)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 35499481

Group type: EXPERIMENTAL
Intervention: 6 mmHg
Number of subjects: 138

Group type: COMPARATOR
Intervention: 15 mmHg
Number of subjects: 138
Study: 33560349

Group type: EXPERIMENTAL
Intervention: LPV/r 400mg/100mg twice daily + RBT 150mg/day (Arm A)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: LPV/r 800mg/200mg twice daily + RIF 600mg/day (Arm B)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: LPV/r 400mg/100mg twice daily + RAL 400mg twice daily + RBT 150mg/day (Arm C)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Historical controls for LPV concentrations
Number of subjects: 71
Study: 33975009

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 IgG antibody response
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 IgG antibody levels
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Memory B-cell response
Number of subjects: 392
Study: 32522121

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation during gestation through 2 years of age
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fresco
Number of subjects: 0
Study: 34740631

Group type: EXPERIMENTAL
Intervention: AdV E4
Number of subjects: 500

Group type: COMPARATOR
Intervention: AdV D8
Number of subjects: 500
Study: 33241426

Group type: EXPERIMENTAL
Intervention: New Harmonic scalpel
Number of subjects: 100

Group type: COMPARATOR
Intervention: Reused Harmonic scalpel
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 34598835

Group type: EXPERIMENTAL
Intervention: Escitalopram or Nortriptyline for 26 weeks
Number of subjects: 90
Study: 33839594

Group type: EXPERIMENTAL
Intervention: Therapy dog intervention prior to the exam
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no therapy dog intervention)
Number of subjects: 80
Study: 32162735

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with eicosapentaenoic and docosahexaenoic acids
Number of subjects: 10

Group type: COMPARATOR
Intervention: Untreated preterm subjects (control group)
Number of subjects: 10
Study: 35764523

Group type: EXPERIMENTAL
Intervention: Matrix acupuncture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 120
Study: 33573664

Group type: EXPERIMENTAL
Intervention: 12-week multimodal Tai Chi rehabilitation program
Number of subjects: 52

Group type: COMPARATOR
Intervention: Postoperative usual care
Number of subjects: 52
Study: 34736855

Group type: EXPERIMENTAL
Intervention: DrugSorb-ATR device
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 120
Study: 33479188

Group type: EXPERIMENTAL
Intervention: Everolimus (EVL) with low-dose tacrolimus (Tac)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Tacrolimus (TAC)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Everolimus (EVL)
Number of subjects: 77
Study: 36027441

Group type: EXPERIMENTAL
Intervention: Central Group (CG)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Peripheral Group (PG)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both Groups
Number of subjects: 59
Study: 34193818

Group type: EXPERIMENTAL
Intervention: Hybrid cycling (cycling with legs via electrical stimulation combined with voluntary handcycling)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Handcycling
Number of subjects: 10
Study: 36071965

Group type: EXPERIMENTAL
Intervention: Probiotic chewable tablet (5 × 10^9 CFU/day, n = 47)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo (n = 45)
Number of subjects: 92
Study: 32539850

Group type: EXPERIMENTAL
Intervention: Hominis placental pharmacopuncture (HPP)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Physical therapy (PT)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Hominis placental pharmacopuncture (HPP) and Physical therapy (PT)
Number of subjects: 82
Study: 33477722

Group type: EXPERIMENTAL
Intervention: Planet Nutrition program (18 nutrition education sessions, 20 physical activity classes, 6 brochures for parents)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Planet Nutrition program
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41